How were FluoroPharma Medical's earnings last quarter?

FluoroPharma Medical, Inc. (OTCMKTS:FPMI) posted its quarterly earnings data on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.01.

What other stocks do shareholders of FluoroPharma Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FluoroPharma Medical investors own include Adicet Bio (ACET) , AB Corporate Bond ETF (EYEG) , Designer Brands (DBI) , Capricorn Energy (CNE) , Comcast (CMCSA) , Casey's General Stores (CASY) , Axos Financial (AX) and Argos Therapeutics (ARGSQ) .

How do I buy shares of FluoroPharma Medical?

Shares of FPMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:FPMI

FluoroPharma Medical (FPMI) Stock Price, News & Analysis

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)

Free FPMI Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings

Get FluoroPharma Medical alerts:

Ad WealthPress

$25,000 into $109,616 in two months?

Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…

Go here to watch the most recent trading workshop video at no charge.

About FluoroPharma Medical Stock (OTCMKTS:FPMI)

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

Ad WealthPress

$25,000 into $109,616 in two months?

Go here to watch the most recent trading workshop video at no charge.

FPMI Stock News Headlines

July 19, 2023 | msn.com

New 'Fluoro Fentanyl' considered 5 times more potent than normal dose, report says

August 30, 2022 | reuters.com

FluoroPharma Medical Inc

April 23, 2024 | The Bull Report (Ad)

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

January 19, 2022 | nasdaq.com

FluoroPharma Medical Inc (FPMI)

See More Headlines

Receive FPMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FluoroPharma Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/14/2015
Today: 4/23/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Diagnostic substances
Sub-Industry: N/A
Current Symbol: OTCMKTS:FPMI
CUSIP: N/A
CIK: 1402785
Web: www.fluoropharma.com
Phone: (973) 744-1565
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 27,580,000
Free Float: 17,401,000
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Dr. Thomas H. Tulip Ph.D. (Age 71)
CEO, President & Director
Comp: $320k
Ms. Tamara Rhein (Age 52)
Chief Financial Officer
Comp: $130k
Mr. Edward L. Lyons Jr.
Vice President of Development

Key Competitors

View All Competitors

FPMI Stock Analysis - Frequently Asked Questions

How were FluoroPharma Medical's earnings last quarter?: FluoroPharma Medical, Inc. (OTCMKTS:FPMI) posted its quarterly earnings data on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.01.
What other stocks do shareholders of FluoroPharma Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other FluoroPharma Medical investors own include Adicet Bio (ACET), AB Corporate Bond ETF (EYEG), Designer Brands (DBI), Capricorn Energy (CNE), Comcast (CMCSA), Casey's General Stores (CASY), Axos Financial (AX) and Argos Therapeutics (ARGSQ).
How do I buy shares of FluoroPharma Medical?: Shares of FPMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FPMI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial